Press release
Animal Drug Compounding Market Is Forecasted To Reach US$ 5.03 Billion By 2034
Animal drug compounding has become integral to veterinary medicine, offering enhanced treatment options and personalized care for pets and animals. With advancements in the veterinary pharmaceutical sector, there is a growing focus on customized medications for animals, marking a significant shift in the industry. This practice involves the formulation of tailored drugs to meet the specific requirements of individual animals, enabling veterinarians to adjust dosages, formulations, and flavors, thereby ensuring optimal treatment adherence and efficacy.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5796
As pet ownership continues to increase worldwide, there is a growing demand for specialized veterinary medications. Pet owners are increasingly seeking personalized treatment options for their animals, driving the expansion of the market for animal drug compounding solutions.
Key Takeaways from Market Study
• The global animal drug compounding market is pegged at US$ 2.32 billion in 2024.
• The market is forecasted to reach US$ 5.03 billion by 2034-end.
• Demand for animal drug compounding solutions is projected to rise at a CAGR of 8% from 2024 to 2034.
• The market in East Asia is predicted to expand at 8% CAGR over the next 10 years.
• The oral route of administration segment is projected to hold 78.9% market share in 2024.
• North America is forecasted to account for 65.7% share of the global market in 2024.
• The companion animal type segment is estimated to account for 54.5% of the market share in 2024.
"As demand for personalized healthcare surges, animal drug compounding serves as a beacon of innovation in veterinary medicine. The ability to create tailored medications offers a new dimension of care, aligning treatment precisely with the needs of individual animals, thereby revolutionizing their well-being," says a Fact.MR analyst.
Top Fortune Companies Profiled in This Report
• Hoye's Pharmacy
• Vertisis Custom Pharmacy
• Smith Caldwell Drug Store
• Sixth Avenue Medical Pharmacy
• Dougherty's Pharmacy
• Medisca Inc.
• Wedgewood Pharmacy
• Triangle Compounding Pharmacy
• Davis Islands Pharmacy
• Custom Med Compounding Pharmacy
• Central Compounding Center South
• Wellness Pharmacy of Cary
• Caringbah Compounding Pharmacy
• Millers Pharmacy
• Smith's Pharmacy
• Specialist Compounding Pharmacy Pte Ltd.
• Tache Pharmacy
• Chiron Compounding Pharmacy
• MEDS Canadian Compounding Pharmacy
• Aurora Compounding
• Pace Pharmacy
• Victoria Compounding Pharmacy
• Pratt's Compounding Pharmacy
• People's Choice Pharmacy
Technological Advancements Driving Production of Customized Medications for Individual Animal Needs
Integration of innovative technologies, such as 3D printing and advanced formulation techniques, has significantly enhanced the precision and efficiency of compounding practices. 3D printing, specifically, has emerged as a game-changer, allowing for the creation of complex dosage forms with unparalleled accuracy. This technology allows compounding pharmacists to create personalized tablets, capsules, and even transdermal patches that suit an animal's individual needs, whether it is altering dosage strengths or combining several treatments into a single dose.
Nanotechnology and microencapsulation technologies have allowed for the encapsulation of active medicinal components, resulting in controlled release and increased medicine bioavailability. These innovations are beneficial in veterinary medicine, where dosing flexibility and palatability are crucial factors in ensuring treatment adherence among animals.
Integration of data-driven technologies has streamlined the compounding process. Advanced software systems aid in dose calculations, inventory management, and quality control, reducing human error and enhancing the overall safety and accuracy of compounded medications. Real-time monitoring and tracking systems also contribute to quality assurance, ensuring that each compounded medication meets stringent regulatory standards.
Country-wise Insights
Why are Animal Drug Compounding Providers Thriving in the United States?
"Combination of Strong Pet Ownership Culture and Advancements in Veterinary Medicine"
The size of the worldwide market for animal medication compounding is significantly influenced by and mostly driven by the United States. The pet ownership culture in the United States is strong, with a significant percentage of households owning companion animals. This enduring bond with pets fuels a sizable market for compounded drugs by driving demand for specialised veterinary medications that perfectly meet each animal's demands.
The nation's veterinary sector demonstrates notable developments in medical technology and therapeutic approaches. This forward-thinking approach to veterinary medicine encourages a rising awareness of the advantages of customised drugs among doctors and pet owners alike. Consumers and veterinarians alike are confident in the effectiveness and dependability of compounded pharmaceuticals because of the United States' strict yet flexible regulatory framework, which guarantees quality control and safety precautions.
Read More: https://www.factmr.com/report/animal-drug-compounding-market
Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Animal Drug Compounding Market Is Forecasted To Reach US$ 5.03 Billion By 2034 here
News-ID: 3563648 • Views: …
More Releases from Fact.MR
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,…
More Releases for Pharmacy
Pharmacy Automation Systems Market Analysis By Top Keyplayers - Inpatient Pharma …
The "Pharmacy Automation Systems Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Pharmacy Automation Systems Market, 2024-2031
Verified Market Research's most recent report, "Pharmacy Automation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides…
Convenient and reliable online pharmacy - Onlinepills pharmacy
Onlinepills Pharmacy is a trusted and reliable online pharmaceutical company that has been serving the global community for over a decade. Onlinepills Pharmacy ensures and prioritizes customer interest with premium customer assistance and the best offers on prescription medicines.
Key Benefits at Onlinepills Pharmacy:
• No prescriptions are asked to order medicines.
• Genuine medicines at the best price.
• Medicines undergo quality checks before shipping in discreet and safe packages.
• Tracking details are provided after shipping…
Pharmacy Compounding For Veterinary Medicine Market Next Big Thing | Medisca, Lo …
Worldwide Pharmacy Compounding For Veterinary Medicine Market In-depth Research Report 2021, Forecast to 2026 is the latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities, and leveraging with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Worldwide Pharmacy Compounding For Veterinary Medicine Market. Some of the key players…
Compounding Pharmacy Market Competitive Outlook Covering COVID-19 Impact | Lorra …
The role of compounding pharmacies is to make drugs prescribed by doctors for specific patients with needs that can't be met by commercially available drugs in the market. Compounded drugs are the amalgamation of two or more drug ingredients in different proportions, i.e., combining or altering the active pharmaceutical ingredients of drugs to meet the unmet medical need of an individual patient. The major driver of compounding pharmacies market is…
Compounding Pharmacy Market SWOT Analysis by Key Players: Olympia Pharmacy, Wedg …
Latest Market intelligence report released by HTF MI with title "Global Compounding Pharmacy Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)" is designed covering micro level of analysis by manufacturers and key business segments. The Global Compounding Pharmacy Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
